213 related articles for article (PubMed ID: 25256437)
21. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Higuchi T; Miyakubo M; Ishikita T; Nakajima T; Endo K
Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
[TBL] [Abstract][Full Text] [Related]
23. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
[TBL] [Abstract][Full Text] [Related]
25. False positive 18F-FDG PET in an ischial chondroblastoma; an analysis of glucose transporter 1 and hexokinase II expression.
Hamada K; Ueda T; Tomita Y; Higuchi I; Inoue A; Tamai N; Myoui A; Aozasa K; Yoshikawa H; Hatazawa J
Skeletal Radiol; 2006 May; 35(5):306-10. PubMed ID: 16333655
[TBL] [Abstract][Full Text] [Related]
26. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
[TBL] [Abstract][Full Text] [Related]
27. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors.
Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Arita H; Nishii R; Tamura S; Kawai K
Nucl Med Commun; 2009 May; 30(5):326-32. PubMed ID: 19282791
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography with 2-deoxy-2-[(18)F] fluoro- d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion.
Yoshioka M; Sato T; Furuya T; Shibata S; Andoh H; Asanuma Y; Hatazawa J; Koyama K
J Gastroenterol; 2003; 38(12):1189-93. PubMed ID: 14714260
[TBL] [Abstract][Full Text] [Related]
30. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer.
Takahashi M; Nojima H; Kuboki S; Horikoshi T; Yokota T; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Ohtsuka M
Pancreatology; 2020 Sep; 20(6):1205-1212. PubMed ID: 32819845
[TBL] [Abstract][Full Text] [Related]
31. Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.
Tohma T; Okazumi S; Makino H; Cho A; Mochiduki R; Shuto K; Kudo H; Matsubara K; Gunji H; Ochiai T
Hepatogastroenterology; 2005; 52(62):486-90. PubMed ID: 15816463
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
[TBL] [Abstract][Full Text] [Related]
33. No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
Charnley N; Airley R; Du Plessis D; West C; Brock C; Barnett C; Matthews J; Symonds K; Bottomly M; Swindell R; Price P
Oncol Rep; 2008 Sep; 20(3):537-42. PubMed ID: 18695903
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
[TBL] [Abstract][Full Text] [Related]
35. Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT.
Toshikuni N; Kai K; Fujisawa M
Ann Nucl Med; 2008 Feb; 22(2):133-7. PubMed ID: 18311538
[TBL] [Abstract][Full Text] [Related]
36. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Higashi T; Tamaki N; Honda T; Torizuka T; Kimura T; Inokuma T; Ohshio G; Hosotani R; Imamura M; Konishi J
J Nucl Med; 1997 Sep; 38(9):1337-44. PubMed ID: 9293783
[TBL] [Abstract][Full Text] [Related]
37. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Reske SN; Grillenberger KG; Glatting G; Port M; Hildebrandt M; Gansauge F; Beger HG
J Nucl Med; 1997 Sep; 38(9):1344-8. PubMed ID: 9293784
[TBL] [Abstract][Full Text] [Related]
39. The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients.
Kaida H; Azuma K; Kawahara A; Yasunaga M; Kitasato Y; Hattori S; Taira T; Ureshino H; Kage M; Ishii K; Murakami T; Ishibashi M
Eur J Radiol; 2016 Oct; 85(10):1804-1810. PubMed ID: 27666620
[TBL] [Abstract][Full Text] [Related]
40. Solid Pseudopapillary Tumor of the Pancreas: A Single-center Experience and Review of the Literature.
Antoniou EA; Damaskos C; Garmpis N; Salakos C; Margonis GA; Kontzoglou K; Lahanis S; Spartalis E; Patsouras D; Kykalos S; Garmpi A; Andreatos N; Pawlik TM; Kouraklis G
In Vivo; 2017; 31(4):501-510. PubMed ID: 28652415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
